AEON Biopharma Inc AEON Q4 2025 Earnings Significant EPS Miss and Stock Decline Amid Development Challenges Tempest Therapeutics Inc TPST Q1 2026 Earnings Significant EPS Miss with No Revenue Stock Edges Up HCWC Q4 2025 Earnings Narrow EPS Beat Highlights Cost Discipline Amid Challenging Environment NUVB Q1 2026 Earnings Small EPS Beat Fails to Lift Shares Amid PreRevenue Stage ICCM Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Development INTU Q1 2026 Earnings EPS Just Misses Estimates Amid Solid Business Momentum